Price Alert

Estrella Immunopharma Inc... (ESLA)

NASDAQ: ESLA · Real-Time Price · USD

0.91

0.05 (5.76%)

At close: Aug 15, 2025, 3:59 PM

0.89

-1.70%

After-hours: Aug 15, 2025, 04:12 PM EDT

Estrella Immunopharma Balance Sheet Statement

Financials in USD. Fiscal year is July - June.

Fiscal Year	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Feb 28, 2021
Cash & Equivalents	1.32M	421.47K	916.92K	1.8M	4.17M	4.73M	9.05M	22.14M	34.69K	29.39K	2.88M	73.75K	88.28K	321.72K	478.87K	772.17K	11.02K	44.5K
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	9.79M	9.7M	9.67M	45.46M	45.26M	45.19M	45.19M	45.19M	3.19M	n/a
Other Long-Term Assets	1.5M	1.5M	1.5M	1.5M	n/a	n/a	n/a	n/a	n/a	n/a	134.38K	n/a	n/a	n/a	n/a	n/a	237.1K	209.68K
Receivables	n/a	n/a	n/a	437.64K	n/a	406.11K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	-406.11K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	163.93K	522.79K	723.86K	n/a	n/a	n/a	n/a	5.07M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Current Assets	1.48M	944.27K	1.64M	2.24M	4.45M	8.63M	9.45M	27.35M	129.36K	81.89K	2.88M	160.75K	128.82K	428.14K	616.03K	780.13K	13.52K	44.5K
Property-Plant & Equipment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	40K	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-9.93M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	1.5M	1.5M	1.5M	1.5M	n/a	n/a	n/a	n/a	10.13M	10.01M	174.38K	45.46M	45.26M	45.19M	45.19M	45.19M	3.43M	209.68K
Total Assets	2.98M	2.44M	3.14M	3.74M	4.45M	8.63M	9.45M	27.35M	10.26M	10.09M	3.05M	45.62M	45.38M	45.62M	45.8M	45.97M	3.44M	254.18K
Account Payables	8.15K	13.99K	n/a	5K	n/a	n/a	77.08K	9.34M	57.35K	n/a	4.31M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	300K	931.67K	735.13K	n/a	498.6K	n/a	n/a	n/a	n/a	180K	100K
Other Current Liabilities	9.07M	4.28M	2.98M	47.05K	129.72K	8.75K	28.2K	5.47M	8.34M	388.1K	n/a	237.15K	154.65K	30.2K	73.15K	100.6K	50K	130K
Total Current Liabilities	9.08M	4.28M	3M	2.99M	180.7K	138.49K	398.73K	17.28M	1.43M	1.22M	4.5M	735.75K	154.65K	30.2K	73.15K	100.6K	230K	230K
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	1.55M	1.55M	5.01M	1.55M	1.55M	1.55M	1.55M	1.55M	3.19M	n/a
Total Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	1.89M	1.87M	5.03M	1.55M	1.55M	1.55M	1.55M	1.55M	3.19M	n/a
Total Liabilities	9.08M	4.28M	3M	2.99M	180.7K	138.49K	398.73K	17.28M	3.33M	3.08M	9.53M	2.29M	1.71M	1.58M	1.62M	1.65M	3.42M	230K
Total Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	300K	931.67K	735.13K	50K	498.6K	n/a	n/a	n/a	n/a	180K	100K
Common Stock	3.76K	3.67K	3.67K	3.66K	3.66K	3.66K	3.52K	3.52K	9.75M	9.54M	123.00	45.32M	45.19M	45.19M	45.19M	45.19M	115.00	115.00
Retained Earnings	-31.58M	-26.03M	-23.93M	-22.88M	-19.5M	-15.55M	-15.08M	-14.06M	-2.82M	-2.53M	-6.72M	-1.98M	-1.51M	-1.15M	-1.01M	-870.54K	-4.37K	-819
Comprehensive Income	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Shareholders Equity	-6.09M	-1.83M	143.73K	746.29K	4.27M	8.49M	9.05M	10.07M	6.93M	7.01M	-6.48M	43.33M	43.68M	44.04M	44.18M	44.32M	20.63K	24.18K
Total Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	9.79M	9.7M	9.67M	45.46M	45.26M	45.19M	45.19M	45.19M	3.19M	n/a